Abstract
Introduction
Endothelial progenitor cells (EPCs) are a circulating, bone marrow derived cell population that can differentiate into mature endothelial cells [1] . Emerging evidence shows that EPCs play a crucial role in neovascularization of ischemic tissue [2, 3] and tumorigenesis [4] . The [3, 5, 6] . However, the exact mechanisms driving EPC mobilization and homing to neovascularization sites are largely unknown. Stromal cell-derived factor 1 (SDF-1) has been confirmed as a principal regulator of retention, migration and mobilization of EPCs during steady-state homeostasis and injury [7, 8] . Reportedly [9, 10] . However, recent studies reported that SDF-1 was also a ligand of a novel chemokine receptor, CXC chemokine receptor 7 (CXCR7) [11, 12] . CXCR7 is widely expressed on haematopoietic system, heart, vascular endothelial cells, bone, kidney and brain [12] [13] [14] [15] [16] . CXCR7 has a significant higher binding affinity for SDF-1 than CXCR4 [12] . [11, 17, 18] . However, these effects of CXCR7 are not observed in other conditions. For instance, during zebrafish development, CXCR7 seems to act as a decoy receptor to scavenge or sequester SDF-1, thereby forming SDF-1 gradient which is critical in guiding proper primordial germ cell migration [19] . Levoye [20] . Collectively, the functions of CXCR7 are very complex. However, most of studies on CXCR7 have focused on cancer biology, and the role of CXCR7 in EPCs remains largely unclear.
processes of EPCs participating in neovascularization are regulated by a variety of growth factors, cytokines and chemokines, which may affect the mobilization, homing, proliferation and differentiation of EPCs

The functions of CXCR7 and its molecular interactions in the cells after binding with SDF-1 remain poorly defined. Some studies revealed that CXCR7 functions as a signalling receptor, promoting cell proliferation, adhesion, chemotaxis and activation of downstream signalling molecules such as extracellular signal-regulated kinase (ERK)1/2 and/or Akt
et al. described that CXCR7 per se does not trigger G␣i protein-dependent signalling, but it can modulate SDF-1-mediated G protein signalling through heterodimerizing with CXCR4
It was confirmed that CXCR7 plays a critical role in foetal endothelial biology, cardiac development and B-cell localization by characterizing CXCR7-deficient mice [21] . The expression of CXCR7 is elevated in endothelial cells associated with tumours [22] . Miao 
Materials and methods
EPCs isolation and characterization
Results
Characterization of EPCs
Bone marrow derived MNCs cultured under endothelial-specific conditions developed a spindle-shaped appearance and typical cell clusters at day 7 after the isolation (Fig. 1A) . (Fig. 1C) , confirming the double positive cells as EPCs.
RT-PCR analysis revealed that the receptors of SDF-1, CXCR4 and CXCR7 were expressed highly in EPCs ( Fig. 2A) , which was also confirmed at the protein level by Western blot analysis (Fig. 2B ) and flow cytometric analysis (Fig. 2C) .
The effects of CXCR7 and CXR4 on EPC adhesion
The adhesion capacity of EPCs to the activated endothelial cells and the extracellular matrix are very important for EPC participating in angiogenesis [28] . We tested whether SDF-1 promotes EPC adhesion to extracellular matrix or endothelial cells using an in vitro cell adhesion assay. As shown in Figure 3A and B, both CXCR7 antibody and CXCR4 antibody significantly inhibit SDF-1-mediated EPC adhesion to collagen (Fig. 3A) and fibronectin (Fig. 3B) . The inhibitory effect of either CXCR7 antibody or CXCR4 antibody was confirmed with either CXCR7 antagonist CCX733 or CXCR4 antagonist AMD3100 (Fig. 3A  and B with anti-CXCR4 antibody or AMD3100 had no such significant effect (Fig. 3C) . It is worth mentioned that the inhibitory effect of blocking both CXCR7 and CXCR4 either with their antibodies or antagonists are similar to that of blocking CXCR7 alone (Fig. 3C) . (Fig. 4A) (Fig. 4B) .
These results thus suggested that both CXCR4 and CXCR7 are essential for SDF-1-mediated EPCs adhesion to extracellular matrix, whereas SDF-1 mediates adhesion of EPCs to endothelial monolayer only via CXCR7.
Fig. 2 The expression of CXCR7 and CXCR4 on EPCs. The expression of CXCR7 and CXCR4 on EPCs was detected by RT-PCR analysis for the mRNA (A) [M: Maker, DL2000; 1: GAPDH (618 bp); 2: CXCR7 (473 bp); 3: CXCR4 (446 bp)] and by Western blot analysis for the protein (B), respectively. GAPDH was used as loading control and HUVECs were used as CXCR7 and CXCR4 expression positive control. The cell surface expression of CXCR7 and CXCR4 was investigated by flow cytometry (C).
Fig. 3 The adhesion properties of EPCs to ECM components and HUVEC induced by SDF-1. EPCs pre-treated with anti-CXCR4 antibody (␣ CXCR4), anti-CXCR7 antibody (␣ CXCR7), IgG control, AMD3100 or CCX733, respectively, were added onto ECM components [collagen (A) and fibronectin (B)] or HUVEC monolayer bond with SDF-1 (C) for 30 min., and then the number of adherent cells was counted in multiple microscopic 10ϫ fields. Data are given as mean Ϯ S.D. (*P Ͻ 0.05; **P Ͻ 0.01 versus control).
Requirement of CXCR4, but not CXCR7, for the migration of EPCs
The chemotactic activity of SDF-1 on EPCs was evaluated in vitro. SDF-1 induced the migration of EPCs in a dose-dependent manner, and 10-100 ng/ml SDF-1 can significantly induce the migration of EPCs
Blocking both CXCR7 and CXCR4 either with their antibodies or antagonists inhibited the migration of EPCs in a similar level to blocking CXCR4 alone (Fig. 4B). The results suggest that SDF-1-induced chemotactic response of EPCs was mainly mediated through CXCR4.
Essentiality of both CXCR4 and CXCR7 for the transendothelial migration of EPCs
The process of EPC mobilizing from bone marrow and engrafting to neo-angiogenesis sites requires transendothelial migration [27] . Thus, the contribution of CXCR4 and CXCR7 to SDF-1-induced transendothelial migration of EPCs via a HUVEC monolayer was also investigated. As shown in Figure 5, 
The effects of CXCR4 and CXCR7 on the proliferation of EPCs
The proliferation of EPCs cultured in growth factor-deprived EBM-2 medium containing 1 ng/ml, 10 ng/ml or 100 ng/ml SDF-1 was measured by MTT. As shown in Figure 6A, 
10-100 ng/ml SDF-1 significantly induced EPCs' proliferation. Because it is known that SDF-1 plays an important role in EPCs' proliferation through CXCR4 receptor [27], the next study was to investigate the role of CXCR7 in EPCs' proliferation. To this end, we treated SDF-1-stimulated EPCs with the antibodies and antagonists of CXCR4 or CXCR7 and then analysed their proliferation rates. MTT assay demonstrated that blocking either CXCR7 or CXCR4 could not significantly reduced the enhancement of EPC proliferation induced by SDF-1, whereas blocking both CXCR7 and CXCR4 significantly inhibited the EPC proliferation induced by SDF-1 (Fig. 6B). Thus SDF-1 enhanced EPCs proliferation is mediated by both of CXCR7 and CXCR4.
The effects of CXCR4 and CXCR7 on EPC survival
To examine the role of CXCR4 and CXCR7 in EPC survival, we determined serum deprivation-induced EPCs apoptosis by flow cytometry with FITC-conjugated annexin V and PI staining. As shown in Figure 7, 
Essentiality of both CXCR4 and CXCR7 for SDF-1-induced tube formation by EPCs
EPCs in EBM-2 medium containing 1 ng/ml, 10 ng/ml or 100 ng/ml SDF-1 was planted on matrigel, and length of tube-like structures was measured. SDF-1 (10-100 ng/ml) significantly induced EPC tube formation (Fig. 8A) . To evaluate the roles of CXCR4 and CXCR7 in SDF-1-induced angiogenesis, we treated SDF-1-stimulated EPCs with CXCR4 and CXCR7 antibodies or antagonists, respectively, and then measured tube length. As shown in Figure  8B , CXCR4 antibody or antagonist AMD3100 significantly decreased the length of SDF-1-induced tubes in comparison of the [9, 10] . However, Burns et al. [11] [19, 30] . Second, in the T lymphocytes CXCR7 its own does not mediate SDF-1-triggered integrin activation but is essential for CXCR4 to mediate SDF-1-dependent integrin activation [31] . In line with this, a recent study also reported that CXCR7 its own did not trigger SDF-1-mediated G protein signalling, but heterodimerized with CXCR4 to form a CXCR7/CXCR4 heterodimer that in turn can initiate SDF-1-mediated signals [20] . Third, CXCR7 also acted as an independent signalling receptor in some tumour cells [23, 32] and peripheral nerve system [17] . Collectively, more and more research on the cellular function of CXCR7 has provided new insights into understanding the puzzling picture.
Fig. 5 Requirement of both CXCR7 and CXCR4 for the transendothelial migration of EPCs. (A) The transendothelial migration of EPCs toward 10 ng/ml SDF-1 was examined by fluorescence microscopy, and one representative image of three independent experiments is presented for each group. Scale bars represent 100 M. (B) Quantitative analysis of the transmigration of EPCs as shown in (A), showing that the transendothelial migration of EPCs induced by SDF-1 (10 ng/ml) is suppressed by pre-treatment with anti-CXCR4 antibody (␣ CXCR4), anti-CXCR7 antibody (␣ CXCR7
)
The role of CXCR7 in EPC adhesion and migration
The first novel finding of the present study is that CXCR4 and CXCR7 have differential roles in EPC migration (Figs 4 and 5 [24] and mesenchymal stem cells [33] was mediated only by CXCR4. However, a few more recent studies suggested that CXCR7 can regulate neuron [34, 35] and tumour cell [36] 
The role of CXCR7 in EPC angiogenesis
The second novel finding is that both CXCR4 and CXCR7 are essential for SDF-1-induced EPC angiogenesis. Previous evidence has indicated that the expression of CXCR7 was frequently up-regulated in tumour-associated endothelial cells and activated endothelial cells [23] , and CXCR7 may promote tumour-associated angiogenesis [39] 
